Full Description
Nanotherapeutics for Treating Neurodegenerative Disorders is a comprehensive guide to the cutting-edge field of nanotherapeutics. This book reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the imperative role of nanotechnology in revolutionizing therapeutic interventions. From explaining the transport mechanisms of the Blood-Brain Barrier to unveiling the therapeutic potential of stem cell-derived nanocarriers, each chapter offers invaluable insights into the diverse array of nanotherapeutic approaches helping to reshape the landscape of neurological healthcare. By consolidating current updates on advanced targets-based nanotherapeutics, this book provides a comprehensive resource for neurodegenerative diseases converge. Whether seeking to unravel the complexities of mitochondrial dysfunction or harness the potential of nanocarriers for targeted genetic material delivery, readers will find themselves equipped with the tools to navigate the forefront of neurotherapeutic innovation.
Contents
1. Concepts, types, and treatment strategies for neurodegenerative disorders
2. Transport mechanisms of the Blood-Brain Barrier
3. Need of nanotherapeutics against neurodegenerative disorders
4. Nanotechnology mediated drug delivery for addressing protein aggregation
5. Nanocarriers focusing on synuclein misfolding as a therapeutic target
6. Therapeutic potential of stem cells derived nanocarriers in neurological disorders
7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders
8. Nanocarriers assisted delivery of genetic material for the treatment of neurodegenerative disorders
9. Nanotherapeutics targeting neuroinflammation
10. Nanocarriers mediated DNA repair mechanism against neurological disorders
11. Nanotherapy for targeted inhibition of PERK: Unravelling stress-induced endoplasmic reticulum kinase
12. Targeting microglial inhibition via nanotechnology: A strategy to halt protein degradation
13. Nanocarriers unveiling ferroptosis as a potential therapeutic target
14. Proteostasis maintenance through nanocarriers: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress
15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders
16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders
17. Targeting glial cells through nanotherapeutic strategies in neurological disorders
18. Oligodendrocytes as an emerging therapeutic target in neurological disorders
